September 21, 2012 – Merck is excited to be participating in several side events during the 67th United Nations General Assembly week. On Tuesday, September 25 Merck will co-host a panel discussion with leading international non-profit PATH entitled Maternal Health Innovations: Accelerating Access to Lifesaving Technologies for the Women Who Need Them Most. The event will provide an opportunity to discuss how maternal health technologies designed for use in some of the poorest regions of the world can accelerate progress to save women's lives during pregnancy and childbirth. A technology exhibit featuring prototypes of maternal health innovations will be available for the audience to view. The event will be moderated by Lois Quam, Executive Director of the U.S. Government's Global Health Initiative and will include maternal health experts from Save the Children and WHO.
Also on September 25, Merck provided support to Women Deliver and Family Care International for a panel discussion titled The Role of Private Providers in Expanding Access to Affordable, Quality Maternal Healthcare. This will provide a forum to discuss how local providers and health businesses can strengthen maternal healthcare in high-burden countries and help bring down alarming rates of maternal mortality. The panel discussion will be moderated by Bloomberg Businessweek's Diane Brady and feature distinguished panelists including Ngozi Okonjo-Iweala, Nigeria's Minister of Finance; Flavia Bustreo, Assistant Director-General for Family, Women and Children's Health at the WHO; Karl Hofmann, President and CEO of Population Services International; and Sweta Mangal, Co-Founder and CEO of Ziqitza Health Care Limited.
In addition, Merck representatives will speak at several high-profile side events during the week. On Friday, September 21, Dr. Julie Gerberding, President of Merck Vaccines, will present at the White Ribbon Alliance for Safe Motherhood's Annual Women's Wake-Up Call for Maternal Health breakfast. Dr. Gerberding will be joined by Arianna Huffington, Sarah Brown, and Donna Karan. This event will focus on the importance of holding governments and health providers accountable for maternal health policy implementation and the provision of quality maternal health services. Dr. Gerberding will speak on the role of community health providers in mobilizing citizens and fostering accountability in Sub-Saharan Africa and beyond.
On Monday, September 24, Dr. Michael Rosenblatt, Executive Vice President and Merck's Chief Medical Officer, will participate in a panel discussion at a high-level event hosted by Jhpiego. The event will be a forum to discuss the interventions, policies, organizations, and solutions that have supported significantly reductions in maternal mortality over the past 20 years.